rhenium has been researched along with Cancer of Nasopharynx in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, K; Li, G; Peng, W; Wang, Y; Zhang, C; Zhang, H | 1 |
| Huang, K; Li, GP; Zhang, H | 1 |
| Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A | 1 |
3 other study(ies) available for rhenium and Cancer of Nasopharynx
| Article | Year |
|---|---|
The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Body Burden; Cell Line, Tumor; Disease Models, Animal; Injections, Intralesional; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Organ Specificity; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Relative Biological Effectiveness; Rhenium; Tissue Distribution; Trastuzumab; Treatment Outcome | 2005 |
[Efficacy of 188Re-herceptin radioimmunotherapy in nude mouse model of nasopharyngeal carcinoma].
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Injections, Intralesional; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Random Allocation; Receptor, ErbB-2; Rhenium; Trastuzumab | 2006 |
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium | 2000 |